Abortions do not increase risk of breast cancerJanuary 26, 2004It is known that previous pregnancy decreases the risk of breast cancer. But a new dissertation from the Karolinska Institutet in Sweden shows that even brief pregnancies terminated prior to full term can have a certain preventive effect. The results could not confirm several earlier studies showing that the risk of developing breast cancer increases among individuals who have had an abortion. It has long been known that pregnancy has a preventive effect against breast cancer, but it is not known why. At the same time, several studies have indicated that abortions or miscarriages seem to increase the risk of breast cancer. This is refuted by a new dissertation from the Department of Medical Epidemiology and Biostatistics at the Karolinska Institutet. We have looked a some 4,000 journals from maternity centers in which women have responded to standardized questions about abortions, among other things, and have not found any correlation between abortions and increased risk of breast cancer. In fact aborted pregnancies had some preventive effect in our study, says Gunnar Larfors, author of the newly defended dissertation. Abortion is still a taboo subject in our society and also entails a trauma, so I believe that many women choose not to report an abortion if they are asked out on the street. But on the other hand, if you ask a person who has been afflicted with breast cancer about previous abortions, the probability is great that they will answer the question truthfully. This can skew the results to make it seem as if breast cancer is tied to abortion. In our study all women had answered the same question before developing breast cancer, says Gunnar Larfors. A study from Denmark based on the Danish abortion register also found no correlation between abortions and increased risk of breast cancer. Preventive effect unclear The dissertation also rejects an earlier hypothesis about how pregnancy protects against breast cancer. A hormone that occurs in high levels during pregnancy, hCG, has evinced a preventive effect against breast cancer in experiments on rats and is already in use in clinical studies in the US. But in several studies we have looked at women who have had extremely high levels of hCG, for example women with severe morning sickness, and have not been able to find any further risk reduction in them. This indicates that hCG is not the hormone to explain the reduced risk of breast cancer after pregnancy in humans, says Gunnar Larfors. Title of dissertation: Pregnancy-related Risk Factors for Breast Cancer Vetenskapsrådet (The Swedish Research Council) |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||